H.C. Wainwright Downgrades Karyopharm Therapeutics (KPTI) to Neutral

July 16, 2025 6:22 AM EDT Send to a Friend
(Updated - July 16, 2025 6:44 AM EDT)

H.C. Wainwright analyst Robert Burns downgraded Karyopharm Therapeutics (NASDAQ: KPTI) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login